SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons and entities who purchased or otherwise acquires shares of Apellis common stock between January 28, 2021 and July 28, 2023. Apellis…Read More
Apellis Pharmaceuticals Inc APLS Investor Alert Robbins LLP Reminds Shareholders of Class Action Against Apellis Pharmaceuticals Inc
